Design rights granted while claiming the Korean novelty grace period have full-scope enforceabilityArticle & News, Articles
Lessons from the two Korean Supreme Court decisions concerning AstraZeneca’s ForxigaArticle & News, Articles
South Korea paves the way for partial refusal system and expedited examinationArticle & News, Articles
